© Rosalind Scientific LLC 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > ABBV-744
<< Back to February
BD2 domain selective BET inhibitor
orally efficacious in XG w/o platelet, GI tox
from SBDD of BD1/2 dual inhibitors
Nature, 2020, 578, 306-310
AbbVie, North Chicago, IL
ABBV-744 (AbbVie oral in vivo BD2 domain selective BET inhibitor)
Unlock this content with a Premium membership to read it now.